- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02403414
Assessment of Airway in Patients With Acromegaly for Predicting Successful Tracheal Intubation
Assessment of Airway in Patients With Acromegaly Undergoing Surgery: Predicting Successful Tracheal Intubation
Acromegaly is associated with increased risk of difficult intubation and its management. The overall incidence of difficult intubation in patients suffering from acromegaly is four to five times more than those without acromegaly.The difficult intubation scenario in these patients can be managed by various methods ranging from awake fiberoptic intubation to tracheostomy. Difficult tracheal intubation accounts for 17% of respiratory-related injuries and results in significant morbidity and mortality in general population. In patients with acromegaly, inability to mask ventilate or intubate can lead to 28% of all anesthesia related deaths. Therefore, the need and importance of airway assessment in patients with acromegaly cannot be overemphasized. Various tests of airway assessment have to be used to assess difficult airway and tracheal intubation in acromegalics.
The investigators aim to assess the various tests of airway assessment affecting the outcome of patients with acromegaly undergoing pituitary surgery and identify which was best suited.
Study Overview
Detailed Description
All the patients of either gender, diagnosed as a case of acromegaly scheduled for pituitary surgery will be enrolled. This observational study will be conducted over a period of 3 years. A written informed consent will be taken from all the patients. The clinical diagnosis will be made on the basis of growth hormone (GH) levels and magnetic resonance imaging (MRI) findings. All patients will be evaluated preoperatively, a day before surgery by an independent observer. Airway assessment for difficult intubation will be performed using Modified Mallampati classification in sitting and supine position followed by mouth opening, upper lip bite test, measurement of thyromental, thyrohyoid, sternomental and hyomental distance. Next the length of upper incisors, presence of receding mandible and neck movement will be checked. An associated history of OSA will also be taken in to account for assessing the difficult intubation followed by OSA grading in acromegalic patients posted for pituitary surgery. In situation of difficult tracheal intubation the fiberoptic intubation would be the preferred choice, which is a gold standard.
General anesthesia will be induced with fentanyl 2µg/kg, propofol 2 mg/kg and rocuronium 1mg/kg. After 90 seconds of mask ventilation, laryngoscopy will be performed with an appropriate sized Macintosh laryngoscope and thereafter Cormac lehane grading will be noted. External laryngeal manipulation (ELM) if carried out will be noted. A standard anesthesia protocol will be followed. After completion of the surgery, neuromuscular blockade will be reversed with neostigmine 0.05mg/kg and glycopyrrolate 0.01mg/kg intravenously. Once the patient follows the verbal command and respiratory parameters are satisfactory, endotracheal tube will be removed. All patients will be shifted to neurosurgical ICU for observation and supportive management.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Indu Kapoor, MD
- Phone Number: 3474 01126588500
- Email: dr.indu.me@gmail.com
Study Contact Backup
- Name: Hemanshu Prabhakar, MD
- Phone Number: 3474 01126588500
- Email: prabhakaraiims@yahoo.co.in
Study Locations
-
-
Delhi
-
New Delhi, Delhi, India, 110029
- Recruiting
- Indu Kapoor
-
Contact:
- Indu Kapoor, MD
- Phone Number: 3474 01126588500
- Email: dr.indu.me@gmail.com
-
Contact:
- Hemanshu Prabhakar, MD
- Phone Number: 3474 01126588500
- Email: prabhakaraiims@yahoo.co.in
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Acromegalic patients undergoing surgery
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Successful tracheal intubation
Time Frame: 10 minutes
|
10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Rate of complications
Time Frame: 24 hours
|
24 hours
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IEC/NP-397/14-11-2014
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acromegaly
-
Andrea M. IsidoriCompletedAcromegaly CardiomyopathyItaly
-
University of CopenhagenOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaboratorsCompletedAcromegaly Due to Pituitary AdenomaDenmark
-
Samsung Medical CenterNot yet recruitingAcromegaly Due to Pituitary AdenomaKorea, Republic of
-
PfizerRecruiting
-
University Hospital, MontpellierRecruiting
-
Ginkgo Leaf Center for Rare DisordersRecruiting
-
National Taiwan University HospitalRecruiting
-
Cedars-Sinai Medical CenterActive, not recruitingAcromegalyUnited States
-
Camurus ABActive, not recruitingAcromegalyUnited States, Spain, United Kingdom, Germany, Russian Federation, Greece, Hungary, Italy, Poland, Turkey, Serbia
-
Crinetics Pharmaceuticals Inc.Active, not recruitingAcromegalyUnited States, Argentina, Belgium, Brazil, Bulgaria, France, Hungary, Israel, Italy, Peru, Poland, Russian Federation, Serbia, United Kingdom
Clinical Trials on Fiberoptic
-
Mansoura UniversityCompleted
-
Ain Shams UniversityCompleted
-
Ain Shams UniversityEnrolling by invitation
-
Assiut UniversityNot yet recruitingLower Respiratory Tract Infection
-
Universidad de AntioquiaCompletedIntubation;DifficultColombia
-
Diskapi Teaching and Research HospitalCompleted
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedTracheal IntubationUnited States
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedIntubation Complication | Intubation, DifficultTaiwan
-
University of MichiganCompletedTobacco Use Disorder | Healthy Participants | Human MicrobiomeUnited States
-
University Hospital, BordeauxCompleted